Jove
Visualize
Contact Us

Related Experiment Videos

Ginger-associated overanticoagulation by phenprocoumon.

Patricia Krüth1, Eberhard Brosi, Richard Fux

  • 1Department of Clinical Pharmacology, Institute for Pharmacology and Toxicology, University Hospital Tübingen, Tübingen, Germany.

The Annals of Pharmacotherapy
|January 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer's Mice.

Pharmaceuticals (Basel, Switzerland)·2021
Same author

Cell motility and migration as determinants of stem cell efficacy.

EBioMedicine·2020
Same author

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.

Cells·2020
Same author

Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2019
Same author

Chronic Heart Failure.

Deutsches Arzteblatt international·2018
Same author

Problems in anticoagulation of a patient with antibiotic treatment for endocarditis: interaction of rifampicin and vitamin K antagonists.

BMJ case reports·2018
Same journal

Association Between Prior PARP Inhibitor Maintenance Therapy and Myelosuppression During Subsequent Chemotherapy in Ovarian Cancer.

The Annals of pharmacotherapy·2026
Same journal

Prolonged Response to Nivolumab in Metastatic Vulvar Carcinoma: Should Immunotherapy be Continued and for How Long? A Debatable Issue!

The Annals of pharmacotherapy·2026
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

This case report details a probable interaction between ginger and phenprocoumon, leading to an elevated international normalized ratio (INR) and bleeding. Discontinuing ginger normalized the INR, highlighting potential risks with herbal supplements during anticoagulation therapy.

Area of Science:

  • Pharmacology
  • Herbal Medicine Interactions
  • Clinical Case Reports

Background:

  • Phenprocoumon is an oral anticoagulant used to prevent blood clots.
  • Ginger is a common herbal supplement with potential effects on hemostasis.
  • Conflicting data exists regarding ginger's impact on platelet function and bleeding risk.

Observation:

  • A 76-year-old woman on phenprocoumon experienced a significant increase in her international normalized ratio (INR) up to 10.
  • The patient also developed epistaxis (nosebleeds) after initiating ginger product use.
  • INR levels returned to the therapeutic range after discontinuing ginger and administering vitamin K1.

Findings:

  • This case suggests a probable interaction between ginger and phenprocoumon, increasing the anticoagulant effect.

Related Experiment Videos

  • The interaction led to a dangerously elevated INR and clinically significant bleeding (epistaxis).
  • This is the first reported case linking ginger consumption to adverse effects in a patient on oral anticoagulation.
  • Implications:

    • Patients on anticoagulants, particularly coumarins, should exercise caution with ginger and other herbal supplements.
    • Healthcare providers should inquire about herbal product use in patients experiencing anticoagulation-related adverse events.
    • Further research is needed to elucidate the mechanisms and clinical significance of ginger-anticoagulant interactions.